Search Results - "Rubio, Thomas T."

Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children by Freeman, Alexandra F., Olivier, Kenneth N., Rubio, Thomas T., Bartlett, Glen, Ochi, James W, Claypool, Reginald J., Ding, Li, Kuhns, Douglas B., Holland, Steven M.

“…Background Nontuberculous mycobacterial (NTM) infection is typically associated with lymphadenitis in immune competent children, and disseminated disease in…”
Get full text

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission by Schaad, U B, abdus Salam, M, Aujard, Y, Dagan, R, Green, S D, Peltola, H, Rubio, T T, Smith, A L, Adam, D

Get more information

Sequential ciprofloxacin therapy in pediatric cystic fibrosis : comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations by CHURCH, D. A, KANGA, J. F, ECHOLS, R. M, KUHN, R. J, RUBIO, T. T, SPOHN, W. A, STEVENS, J. C, PAINTER, B. G, THURBERG, B. E, HAVERSTOCK, D. C, PERRONCEL, R. Y

Get full text

Abdominal actinomycosis with hydronephrosis in childhood by CAMPO, JENIFFER M, RUBIO, THOMAS T, CHURCHILL, ROBIN B, FISHER, RANDALL G

“…Two 11-year-old boys had similar clinical courses of abdominal actinomycosis complicating ruptured appendicitis and manifesting as abdominal masses causing…”
Get full text

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates by Weisman, Leonard E., Stoll, Barbara J., Kueser, Thomas J., Rubio, Thomas T., Frank, C.Gilbert, Heiman, Howard S., Subramanian, K.N.Siva, Hankins, Charles T., Cruess, David F., Hemming, Val G., Fischer, Gerald W.

“…To determine whether a single dose of intravenously administered immune globulin (IVIG) decreases late-onset sepsis in premature infants, we prospectively…”
Get full text

Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation by Rubio, T T, Miles, M V, Lettieri, J T, Kuhn, R J, Echols, R M, Church, D A

“…Information about the pharmacokinetics of fluoroquinolone antibiotics in high risk children is scant. This study examined the disposition of sequentially…”
Get full text

Panel discussion: antimicrobial therapy in pediatric cystic fibrosis patients by SCHAAD, URS B., RUBIO, THOMAS T., KANGA, JAMSHED F., STUTMAN, HARRIS, SMITH, ARNOLD

Get full text

MATERNAL-FETAL TRANSMISSION OF HIV IN SOUTHEASTERN VIRGINIA: IMPACT OF PERINATAL ZIDOVUDINE (ZDV) USE. • 638 by Mitchell, Douglas K, Treichler, D. Brent, Dattel, Bonnie J, Rubio, Thomas T

Get full text

Intravenous immune globulin therapy for early-onset sepsis in premature neonates by Weisman, L E, Stoll, B J, Kueser, T J, Rubio, T T, Frank, C G, Heiman, H S, Subramanian, K N, Hankins, C T, Anthony, B F, Cruess, D F

“…Newborn infants may have IgG deficiencies that increase their susceptibility to bacterial infection. To determine whether intravenous immune globulin (IVIG)…”
Get more information

Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis by Rubio, T T

Get more information

Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients by Rubio, T T, Shapiro, C

“…Ten patients with cystic fibrosis received 19 therapeutic courses of ciprofloxacin at a dose of 750 mg orally twice daily. The length of therapy ranged from…”
Get more information

Infection in patients with cystic fibrosis by Rubio, T T

“…Cystic fibrosis is the most common lethal genetic disease of Caucasians. The disease affects the exocrine gland secretions throughout the body, and as a…”
Get more information

Ciprofloxacin in the Treatment of Pseudomonas Infection in Patients with Cystic Fibrosis by Thomas T. Rubio, Shapiro, Carol

Get full text

Developmental pharmacokinetics of mezlocillin in newborn infants by Janicke, D M, Rubio, T T, Wirth, Jr, F H, Karotkin, E H, Jusko, W J

“…Single-dose pharmacokinetics of mezlocillin were studied in 53 newborn infants (72% less than or equal to 36 weeks' gestation) given ampicillin and an…”
Get more information

Developmental pharmacokinetics of mezlocillin in 4 newborn infants by Jungbluth, G L, Wirth, Jr, F H, Rubio, T T, Janicke, D M, Jusko, W J

“…The disposition of mezlocillin was evaluated in 4 newborn infants in a sequential two-phase study at postnatal ages of 1 day and 8 or 10 days. Renal function…”
Get more information